LONDON (Alliance News) - Mixed data in Europe and the US Wednesday has kept equity markets subdued ahead of the major US jobs report and central bank meetings still to come this week. Meanwhile the pound has underperformed other major currencies after an unexpected drop in UK service sector activ Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported higher fourth quarter profits as revenues increased and it cut costs, and it confirmed that it expects to launch late stage clinical trials on ten new drugs over the next two years. The performance was driven by str Read More
LONDON (Alliance News) - The FTSE 100 is on the verge of snapping a five day losing streak Wednesday, led higher by the likes of<strong> RSA Insurance Group</strong>, which unveiled its new chief executive, and<strong> GlaxoSmithKline</strong>, which has just reported strong results. <br /><br Read More
LONDON (Alliance News) - US stocks are called to open in negative territory Wednesday, having closed firmly higher Tuesday, as investors take a step back ahead of a raft of US macro-economic data. Wall Street shook off recent weaknesses to close higher Tuesday, with the DJIA closing up 0.5% Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported higher fourth quarter profits as revenues increased and it cut costs, and it confirmed that it expects to launch late stage clinical trials on ten new drugs over the next two years. The performance was driven by str Read More
LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Hargreaves Lansdown</strong> PLC reported record pretax profit and revenue for the half year, as it continues to add new clients amid Read More
LONDON (Alliance News) - UK equities are set for yet another negative start Wednesday as investors await a raft of macro-economic data from the UK, the US, and Europe and despite a higher close on Wall Street overnight. Meanwhile, some London-based traders may be struggling to get to their Read More
LONDON (Alliance News) - The FTSE 100 closed lower for a fifth consecutive day Tuesday, even though the index was higher at one point, as concerns about the impact of the Federal Reserve's tapering of its economic stimulus programme continued to weigh on stock markets across the world.<br /><b Read More
LONDON (Alliance News) - The UK's two largest pharmaceuticals companies will report 2013 earnings this week, with AstraZeneca expected to show a fourth quarter loss when it reports Thursday, while GlaxoSmithKline profits are expected to have flatlined over the year as a whole. Both companie Read More
LONDON (Alliance News) - LONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said Executive Director Moncef Slaoui was allocated 17 American Depositary Shares at a price of USD51.54 each Friday. Glaxo shares were up 0.8% at 1,576.50 pence Monday. B Read More
LONDON (Alliance News) - UK banks are still counting the cost of their product mis-selling, with Lloyds Banking Group Monday adding a further GBP1.93 billion to the amount it has set aside to cover claims for previous sales of payment protection insurance and interest rate hedging products. <p Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br /><br />-------<br /><br /><strong>FTSE 100 - WINNERS</strong><br /><br /><strong>Randgold Resources</strong>, up 2.1%. In a difficult environment for gold miners, Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it had received Breakthrough Therapy designation for its bone marrow disorder treatment Promacta/Revolade from the US Food and Drug Administration. The treatment is designed for patients with severe aplastic anemia, a rare disord Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it had received Breakthrough Therapy designation for its bone marrow disorder treatment Promacta/Revolade from the US Food and Drug Administration. The treatment is designed for patients with severe aplastic anemia, a rare disord Read More
LONDON (Alliance News) - GlaxoSmithKline PLC will this week announce plans to launch late stage clinical trials on ten new drugs over the next two years, the Daily Telegraph reported Monday, without saying where it got the information. The list will include medicines in Glaxo?s key areas of Read More